• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血因子 VIII 的膜结合动力学表明这是一个复杂的结合过程。

Membrane binding kinetics of factor VIII indicate a complex binding process.

作者信息

Bardelle C, Furie B, Furie B C, Gilbert G E

机构信息

Center for Hemostasis and Thrombosis Research, New England Medical Center, Boston, Massachusetts.

出版信息

J Biol Chem. 1993 Apr 25;268(12):8815-24.

PMID:8473326
Abstract

Factor VIII functions as a component of the tenase enzyme complex upon phospholipid membranes. Factor VIII binds to phosphatidylserine-containing membranes and apparently provides high affinity binding sites for factor IXa upon these membranes. We have characterized the binding kinetics of human factor VIII with phosphatidylserine-containing membranes and directly compared the measured properties with those of factor V. The initial phase of association was evaluated in a stopped-flow apparatus by fluorescence energy transfer from aromatic residues in the protein to dansyl-labeled phosphatidylethanolamine in the vesicles. Association proceeded at an apparent second-order rate of 0.12 microM-1 s-1 for extruded phospholipid vesicles and 0.42 microM-1 s-1 for sonicated vesicles under pseudo-first-order conditions in which the phospholipid concentration determined the rate. Increased temperature resulted in more rapid association, and the effect decreased in the order extruded vesicles > sonicated vesicles > extruded vesicles of dioleoylphospholipids, indicating that the structure of the phospholipid membrane contributes to the activation energy of binding. The binding of fluorescein-labeled factor VIII to membranes supported on glass microspheres (lipospheres) was monitored by flow cytometry. Under conditions in which the factor VIII concentration determined the rate there was rapid initial association at 6.9 microM-1 s-1, accounting for half of the bound factor VIII, and a slower component of 0.87 microM-1 s-1, accounting for the other half. Likewise, the dissociation of factor VIII from liposphere membranes was biphasic with a faster component of 0.010 s-1 and a slower component of 0.0012 s-1. Rates of association and dissociation for factor V were similar to those for factor VIII and were biphasic. These results allow estimation of the size of the phospholipid sites that interact with factors VIII and V and suggest that both proteins bind to membranes via a multistep process in which rapid association is followed by a slower step yielding higher affinity binding.

摘要

凝血因子 VIII 在磷脂膜上作为凝血酶原酶复合物的一个组成部分发挥作用。凝血因子 VIII 与含磷脂酰丝氨酸的膜结合,显然在这些膜上为凝血因子 IXa 提供高亲和力结合位点。我们已对人凝血因子 VIII 与含磷脂酰丝氨酸的膜的结合动力学进行了表征,并将测得的特性与凝血因子 V 的特性直接进行了比较。结合的初始阶段在停流装置中通过从蛋白质中的芳香族残基到囊泡中丹磺酰标记的磷脂酰乙醇胺的荧光能量转移来评估。在伪一级条件下,对于挤出的磷脂囊泡,结合以 0.12 μM⁻¹ s⁻¹ 的表观二级速率进行,对于超声处理的囊泡,结合速率为 0.42 μM⁻¹ s⁻¹,其中磷脂浓度决定速率。温度升高导致结合更快,其影响程度按挤出囊泡>超声处理囊泡>二油酰磷脂挤出囊泡的顺序降低,表明磷脂膜的结构有助于结合的活化能。通过流式细胞术监测荧光素标记的凝血因子 VIII 与玻璃微球(脂质球)上支持的膜的结合。在凝血因子 VIII 浓度决定速率的条件下,初始结合迅速,速率为 6.9 μM⁻¹ s⁻¹,占结合的凝血因子 VIII 的一半,较慢的组分速率为 0.87 μM⁻¹ s⁻¹,占另一半。同样,凝血因子 VIII 从脂质球膜上的解离是双相的,较快的组分为 0.010 s⁻¹,较慢的组分为 0.0012 s⁻¹。凝血因子 V 的结合和解离速率与凝血因子 VIII 相似,也是双相的。这些结果有助于估计与凝血因子 VIII 和 V 相互作用的磷脂位点的大小,并表明这两种蛋白质都通过多步过程与膜结合,其中快速结合之后是较慢的步骤,产生更高亲和力的结合。

相似文献

1
Membrane binding kinetics of factor VIII indicate a complex binding process.凝血因子 VIII 的膜结合动力学表明这是一个复杂的结合过程。
J Biol Chem. 1993 Apr 25;268(12):8815-24.
2
Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres).含磷脂酰丝氨酸的膜结合位点对凝血因子VIII的特异性。使用玻璃微球(脂质球)支撑的模型膜进行的研究。
J Biol Chem. 1992 Aug 5;267(22):15861-8.
3
Binding of human factor VIII to phospholipid vesicles.人凝血因子 VIII 与磷脂囊泡的结合。
J Biol Chem. 1990 Jan 15;265(2):815-22.
4
Platelet-derived microparticles express high affinity receptors for factor VIII.血小板衍生微粒表达因子VIII的高亲和力受体。
J Biol Chem. 1991 Sep 15;266(26):17261-8.
5
Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry.通过椭圆偏振法测定凝血因子VIII及其轻链与磷脂酰丝氨酸/磷脂酰胆碱双层膜的结合。
Biochem J. 1995 Sep 1;310 ( Pt 2)(Pt 2):539-45. doi: 10.1042/bj3100539.
6
Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.凝血酶对因子VIII的激活增加了其与合成磷脂膜及活化血小板结合的亲和力。
J Biol Chem. 1998 Oct 23;273(43):27918-26. doi: 10.1074/jbc.273.43.27918.
7
Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.不饱和磷脂酰链是构成凝血因子 VIII 膜结合位点所必需的。
Biochemistry. 1998 Sep 29;37(39):13526-35. doi: 10.1021/bi972944f.
8
Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature.乳黏素选择性地结合含有磷脂酰-L-丝氨酸且曲率增加的膜。
Biochim Biophys Acta. 2004 Nov 17;1667(1):82-90. doi: 10.1016/j.bbamem.2004.09.006.
9
Phosphatidylethanolamine induces high affinity binding sites for factor VIII on membranes containing phosphatidyl-L-serine.磷脂酰乙醇胺在含有磷脂酰-L-丝氨酸的膜上诱导因子 VIII 的高亲和力结合位点。
J Biol Chem. 1995 Aug 4;270(31):18500-5. doi: 10.1074/jbc.270.31.18500.
10
Membrane-binding peptide from the C2 domain of factor VIII forms an amphipathic structure as determined by NMR spectroscopy.通过核磁共振光谱测定,来自凝血因子VIII C2结构域的膜结合肽形成两亲结构。
Biochemistry. 1995 Mar 7;34(9):3022-31. doi: 10.1021/bi00009a033.

引用本文的文献

1
Uncovering Membrane-Bound Models of Coagulation Factors by Combined Experimental and Computational Approaches.通过联合实验和计算方法揭示凝血因子的膜结合模型。
Thromb Haemost. 2021 Sep;121(9):1122-1137. doi: 10.1055/s-0040-1722187. Epub 2021 Jul 2.
2
Factor VIII-antibody structure and membrane binding.VIII 因子抗体结构与膜结合。
Blood. 2021 May 27;137(21):2866-2868. doi: 10.1182/blood.2021010947.
3
Modeling Thrombin Generation in Plasma under Diffusion and Flow.在扩散和流动条件下的血浆中凝血酶生成的建模。
Biophys J. 2020 Jul 7;119(1):162-181. doi: 10.1016/j.bpj.2020.04.033. Epub 2020 May 19.
4
The 3.2 Å structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain.凝血因子VIII生物工程变体的3.2 Å结构表明C2结构域存在两种构象。
J Thromb Haemost. 2020 Jan;18(1):57-69. doi: 10.1111/jth.14621. Epub 2019 Sep 8.
5
The Journey of Protein S from an Anticoagulant to a Signaling Molecule.蛋白S从抗凝剂到信号分子的历程。
JSM Biochem Mol Biol. 2016;3(1). Epub 2016 Aug 8.
6
Discovery of the Membrane Binding Domain in Trifunctional Proline Utilization A.三功能脯氨酸利用A中膜结合结构域的发现
Biochemistry. 2017 Nov 28;56(47):6292-6303. doi: 10.1021/acs.biochem.7b01008. Epub 2017 Nov 15.
7
Binding of Factor VIII to Lipid Nanodiscs Increases its Clotting Function in a Mouse Model of Hemophilia A.在A型血友病小鼠模型中,凝血因子VIII与脂质纳米盘的结合增强了其凝血功能。
J Blood Disord Transfus. 2015 Dec;6(6):325. doi: 10.4172/2155-9864.1000325. Epub 2015 Dec 18.
8
Membrane Interaction of the Factor VIIIa Discoidin Domains in Atomistic Detail.凝血因子VIIIa盘状结构域与膜相互作用的原子水平细节
Biochemistry. 2015 Oct 6;54(39):6123-31. doi: 10.1021/acs.biochem.5b00417. Epub 2015 Sep 30.
9
Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.VIII 因子和 V 因子的 C2 结构域中的保守突变改变了磷脂结合和辅因子活性。
Blood. 2012 Aug 30;120(9):1923-32. doi: 10.1182/blood-2012-01-408245. Epub 2012 May 21.
10
Increasing vaccine potency through exosome antigen targeting.通过外泌体抗原靶向作用提高疫苗效力。
Vaccine. 2011 Nov 21;29(50):9361-7. doi: 10.1016/j.vaccine.2011.09.133. Epub 2011 Oct 12.